近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Feng Z, Tong WK, Zhang X, Tang Z (通讯作者). Cost-effectiveness analysis of once-daily oral semaglutide versus placebo and subcutaneous glucagon-like peptide-1 receptor agonists added to insulin in patients with type 2 diabetes in China. Front Pharmacol. 2023; 14:1226778.
Feng Z, Tong WK, Zhang X, Tang Z (通讯作者). Prevalence of depression and association with all-cause and cardiovascular mortality among individuals with type 2 diabetes: a cohort study based on NHANES 2005–2018 data. BMC Psychiatry. 2023; 23(1):490.
Gu M, Li A, Mak W, Dong F, Xu N, Zhang J, Shi Y, Zheng N, Tang Z, He Q, Ruan C, Guo W, Xiang X, Wang C, Han B, Zhu X. Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization. Front Pharmacol. 2023; 14:1089862.
Yuan Y, Li Z, Wang K, Zhang S, He Q, Liu L, Tang Z, Zhu X, Chen Y, Cai W, Peng C, Xiang X. Pharmacokinetics of novel furoxan/coumarin hybrids in rats using LC-MS/MS method and physiologically based pharmacokinetic model. Molecules. 2023; 28(2):837.
Lin J, Li M, Mak W, Shi Y, Zhu X, Tang Z, He Q, Xiang X. Applications of in silico models to predict drug-induced liver injury. Toxics. 2022; 10(12):788.
Jia Q, He Q, Yao L, Li M, Lin J, Tang Z, Zhu X, Xiang X. Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules. 2022; 27(24):8670.
Feng Z, Ye Y, Ye H, Tang Z (通讯作者). Changes in pharmaceutical retail market and regional inequality of community pharmacists accessibility in mainland China: a retrospective cross-sectional study. BMJ Open. 2022; 12:e063739.
Feng Z, Li X, Tong WK, He Q, Zhu X, Xiang X, Tang Z (通讯作者). Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS. Front Pharmacol. 2022; 13:894685.
Feng Z, Tong WK, Tang Z (通讯作者). Longitudinal trends in the prevalence and treatment of depression among adults with cardiovascular disease: An analysis of national health and nutrition examination survey 2009–2020. Front Psychiatry. 2022; 13:943165.
Tang Z (第一作者), Fan X, Feng Z, Han B, Guo N. Case Report: Rhabdomyolysis secondary to vildagliptin overdose in a suicidal attempt: A case report and brief literature review. Front Pharmacol. 2022; 13:955162.
Tang Z (第一作者), Shen C, Tong WK, Xiang X, Feng Z, Han B. Frailty in community-dwelling adults aged 40 years and over with type 2 diabetes: association with self-management behaviors. Int J Environ Res Public Health. 2022; 19(15):9092.
Zhang J, Tang Z, Guo X, Wang Y, Zhou Y, Cai W. Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene. Front Oncol. 2022; 12:933646.
郭楠, 韩冰, 喻轶群, 王晓娟, 刘宏锐, 冯振, 唐至佳(通讯作者). 基于智慧医疗构建糖尿病药学门诊的必要性及应用初探. 中国临床药学杂志. 2022; 31(07):495-499.
冯振, 叶桦, 唐至佳 (通讯作者). 社会药房执业药师针对处方药和非处方药开展药学服务的同异性. 中国临床药学杂志. 2022; 31(04):298-301.
Yuan Y, He Q, Zhang S, Li M, Tang Z, Zhu X, Jiao Z, Cai W, Xiang X. Application of physiologically-based pharmacokinetic modeling in preclinical studies: a feasible strategy to practice the principles of 3Rs. Front Pharmacol. 2022; 13:895556.
He Q, Bu F, Wang Q, Li M, Lin J, Tang Z, Mak WY, Zhuang X, Zhu X, Lin H, Xiang X. Examination of the impact of CYP3A4/5 on drug–drug interaction between schizandrol A/schizandrol B and tacrolimus (FK-506): a physiologically based pharmacokinetic modeling approach. Int J Mol Sci. 2022; 23(9): 4485.
冯振, 白玛拉姆, 叶桦, 洪兰, 唐至佳 (通讯作者). 我国社会药房执业药师药学服务能力研究. 药物流行病学杂志. 2021; 30(05):342-346.
He Q, Bu F, Zhang H, Wang Q, Tang Z, Yuan J, Lin H, Xiang X. Investigation of the impact of CYP3A5 polymorphism on drug-drug interaction between tacrolimus and schisantherin A/schisandrin A based on physiologically-based pharmacokinetic modeling. Pharmaceuticals. 2021; 14(3):198.
Li M, He Q, Yao L, Wang X, Tang Z, Zhu X, Lin H, Xiang X. Simultaneous Quantification of Propylthiouracil and Its N-β-d Glucuronide by HPLC-MS/MS: Application to a Metabolic Study. Pharmaceuticals. 2021; 14(11):1194.
Wang Z, Xiang X, Liu S, Tang Z, Sun H, Parvez M, Ghim J, Shin J, Cai W. A physiologically based pharmacokinetic/pharmacodynamic modeling approach for drug-drug interaction evaluation of warfarin enantiomers with sorafenib. Drug Metab Pharmacokinet. 2021; 39:100362.
Tang Z (第一作者), Jiang X, Hong L, Feng Z, He Q, Yuan J, Xiang X. Validation of the simplified Chinese version of the brief Diabetes Quality of Life (DQoL) questionnaire based on a cross-sectional study. Int J Environ Res Public Health. 2020; 17(23):8792.
Tang Z (第一作者), Lhamu P, Ye H, Hong L, Xiang X. Current perceptions and improvement approaches of pharmaceutical care capacity of community pharmacists: a quantitative analysis based on survey data at Chinese chain pharmacies. Int J Environ Res Public Health. 2020; 17(20):7482.
唐至佳 (第一及通讯作者), 叶桦. 关于部分发达国家（执业）药师继续教育管理现状分析. 中国药事. 2020; 34(12):1408-1413.
Wu W, Wang Y, Tang Z, Gao Y, Huo Y. Regulatory oversight of cell therapy in China: Government's efforts in patient access and therapeutic innovation. Pharmacol Res. 2020; 158:104889.
Wang Z, Xue Y, Sun H, Zhang Z, Tang Z, Liu S, Cai W. Effect of tea polyphenols on the oral and intravenous pharmacokinetics of ticagrelor in rats and its in vitro metabolism. J Food Sci. 2020; 85(4):1285-1291.
Wu W, Tang Z (共同一作), Chen J, Gao Y. Pediatric Drug Development in China Reforms and Challenges. Pharmacol Res. 2019; 148:104412.
唐至佳 (第一及通讯作者), 叶桦. 执业药师资格考试电子化的可行性探讨. 中国药事. 2019; 33(1):26-31.
Li X, Jin S, Fan Y, Fan X, Tang Z, Cai W, Yang J, Xiang X. Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients. Biomed Pharmacother. 2019; 117:109095.
Wang L, Fan Z, Zhang J, Changyi Y, Huang C, Gu Y, Xu Z, Tang Z, Lu W, Wei X, Li C. Evaluating tumor metastatic potential by imaging intratumoral acidosis via pH-activatable near-infrared fluorescent probe. Int J Cancer. 2015; 136(4):E107-16.1.
京公网安备 11010802027423号